Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host virtual 1x1 investor meetings at the Oppenheimer 34th Annual Healthcare Life Sciences Conference.

Oppenheimer 34th Annual Healthcare Life Sciences Conference Fireside Chat: Wednesday, February 14, 2024 at 10:00 am ET Location: Virtual

A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com.

About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:Media & InvestorsSarah Spencer +1 857-242-6076sspencer@vorbio.com

Vor Biopharma (NASDAQ:VOR)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas Vor Biopharma.
Vor Biopharma (NASDAQ:VOR)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas Vor Biopharma.